Program areas at PhRMA
Public policy advocacy: Phrma's mission is to conduct effective advocacy for public policies that encourage discovery of important new medicines for patients by biopharmaceutical Research companies. Phrma achieves this mission by working with, and on behalf of, its member companies before governmental and regulatory bodies in the united states and throughout the world in support of pro-patient, pro-innovation policies. Specifically, Phrma advocates for broad patient access to safe and effective medicines through a free market, without government price controls; strong intellectual property incentives; and transparent, efficient regulation and a free flow of information to patients.
General education about biopharmaceutical industry: Phrma disseminates information about biopharmaceutical companies, their products, and their business, scientific and philanthropic activities through a wide range of channels, including profiles, reports, principles, guidelines, fact sheets, policy papers and other resources. These efforts bolster Phrma's ability to educate and inform members of the general public as well as policymakers, the media, patients and others in the health care community about the biopharmaceutical industry and Phrma's public policy activities in particular.
Member services: in representing the country's leading Pharmaceutical Research and biotechnology companies, Phrma provides a forum for member companies to participate in discussions of relevant health care issues and to develop consensus positions on matters of public policy advocacy. Member companies participate in Phrma activities through representation on the board of directors, board-level committees, staff work groups, sections, and task forces. Member company representatives also regularly communicate with Phrma staff.